Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects

Steven Dooley1, Harun M Said, Axel M Gressner

  • 1Institute of Clinical Chemistry and Pathobiochemistry, University Hospital Aachen, RWTH-Aachen, Germany. steven.dooley@med.ma.uni-heidelberg.de

Insights

Y-box protein-1 (YB-1) activates Smad7 via Jak1 signaling, reducing collagen expression. This interferon-gamma-mediated pathway offers an antifibrotic mechanism by interfering with TGF-beta signaling.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Signaling

Background:

  • Y-box protein-1 (YB-1) is recognized as a negative regulator of collagen (Col) expression.
  • YB-1 exerts its regulatory function through direct promoter binding or interaction with p300/Smad3, inhibiting transforming growth factor-beta (TGF-beta) signaling.

Purpose of the Study:

  • To investigate the role of YB-1 in interferon-gamma (IFN-γ)-dependent gene regulation.
  • To elucidate the mechanism by which YB-1 mediates antifibrotic effects.

Main Methods:

  • Analysis of YB-1 activation through the Jak1 signaling pathway.
  • Chromatin immunoprecipitation assays to assess YB-1 binding to the smad7 promoter.
  • Reporter gene assays to quantify gene expression.
  • Overexpression studies to evaluate the impact on TGF-beta signaling and collagen expression.

Main Results:

  • YB-1 activation via Jak1 signaling is essential and sufficient for IFN-γ-dependent activation of the smad7 gene.
  • YB-1 binds to the smad7 promoter, up-regulating its transcription, an effect additively enhanced by TGF-beta signaling.
  • YB-1 overexpression inhibits TGF-beta-induced collagen expression, demonstrating an anti-TGF-beta effect independent of Smad7 induction.

Conclusions:

  • YB-1 is a key mediator of IFN-γ signaling through Jak1, exhibiting antifibrotic properties.
  • YB-1 exerts antifibrotic action by both inhibiting TGF-beta signaling and directly down-regulating collagen expression.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...